This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Cowley, D. O. Articles by Van Dyke, T. Search for Related Content PubMed PubMed Citation Articles by Cowley, D. O. Articles by Van Dyke, T. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Medline Plus Health Information Thyroid Cancer

 Previous Article  |  Next Article 

Molecular and Cellular Biology, September 2005, p. 7796-7802, Vol. 25, No. 17
0270-7306/05/$08.00+0     doi:10.1128/MCB.25.17.7796-7802.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

A Dominant Interfering Bub1 Mutant Is Insufficient To Induce or Alter Thymic Tumorigenesis In Vivo, Even in a Sensitized Genetic Background

Dale O. Cowley, Ginger W. Muse, and Terry Van Dyke^*

Department of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina 27599

Received 25 October 2004/ Returned for modification 23 November 2004/ Accepted 7 June 2005

Aneuploidy is a common feature of human tumors, often correlating with poor prognosis. The mitotic spindle checkpoint is thought to play a major role in aneuploidy suppression. To investigate the role of the spindle checkpoint in tumor suppression in vivo, we developed transgenic mice in which thymocytes express a dominant interfering fragment of Bub1, a kinase regulator of the spindle checkpoint. We report that, despite high-level expression of dominant-negative Bub1 (Bub1DN), a protein known to inhibit spindle checkpoint activity in cultured cells, thymocytes show no evidence of spindle checkpoint impairment. Transgenic animals also failed to show an increased predisposition to spontaneous tumors. Moreover, the Bub1DN transgene failed to alter the timing or characteristics of thymic lymphoma development in p53 heterozygous or homozygous null backgrounds, indicating that the lack of tumorigenesis is not due to suppression by p53-dependent checkpoints. These results indicate that overexpression of a Bub1 N-terminal fragment is insufficient to impair the spindle checkpoint in vivo or to drive tumorigenesis in the highly susceptible murine thymocyte system, either alone or in combination with G₁ checkpoint disruption.

---

* Corresponding author. Mailing address: CB7295, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599. Phone: (919) 962-2145. Fax: (919) 843-3160. E-mail: tvdlab{at}med.unc.edu.

---

Molecular and Cellular Biology, September 2005, p. 7796-7802, Vol. 25, No. 17
0022-538X/05/$08.00+0     doi:10.1128/MCB.25.17.7796-7802.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Schliekelman, M., Cowley, D. O., O'Quinn, R., Oliver, T. G., Lu, L., Salmon, E.D., Van Dyke, T. (2009). Impaired Bub1 Function In vivo Compromises Tension-Dependent Checkpoint Function Leading to Aneuploidy and Tumorigenesis. Cancer Res. 69: 45-54 [Abstract] [Full Text]  
• Niikura, Y., Dixit, A., Scott, R., Perkins, G., Kitagawa, K. (2007). BUB1 mediation of caspase-independent mitotic death determines cell fate. JCB 178: 283-296 [Abstract] [Full Text]